title: Protective effect of Qnr on agents other than quinolones that target DNA gyrase.
abstract: Qnr is a plasmid-encoded and chromosomally determined protein that protects DNA gyrase and topoisomerase IV from inhibition by quinolones. Despite its prevalence worldwide and existence prior to the discovery of quinolones, its native function is not known. Other synthetic compounds and natural products also target bacterial topoisomerases. A number were studied as molecular probes to gain insight into how Qnr acts. Qnr blocked inhibition by synthetic compounds with somewhat quinolone-like structure that target the GyrA subunit, such as the 2-pyridone ABT-719, the quinazoline-2,4-dione PD 0305970, and the spiropyrimidinetrione pyrazinyl-alkynyl-tetrahydroquinoline (PAT), indicating that Qnr is not strictly quinolone specific, but Qnr did not protect against GyrA-targeting simocyclinone D8 despite evidence that both simocyclinone D8 and Qnr affect DNA binding to gyrase. Qnr did not affect the activity of tricyclic pyrimidoindole or pyrazolopyridones, synthetic inhibitors of the GyrB subunit, or nonsynthetic GyrB inhibitors, such as coumermycin A1, novobiocin, gyramide A, or microcin B17.Thus, in this set of compounds the protective activity of Qnr was confined to those that, like quinolones, trap gyrase on DNA in cleaved complexes.
authors.affiliation: Lahey Hospital and Medical Center, Burlington, Massachusetts, USA gajacoby50@gmail.com.
authors.forename: George A
authors.initials: GA
authors.lastname: Jacoby
authors.affiliation: Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
authors.forename: Marian A
authors.initials: MA
authors.lastname: Corcoran
authors.affiliation: Massachusetts General Hospital, Boston, Massachusetts, USA.
authors.forename: David C
authors.initials: DC
authors.lastname: Hooper
mesh_terms: D049933:Aminocoumarins; D001430:Bacteriocins / Q000494:pharmacology; D027081:DNA Gyrase / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism*; D009675:Novobiocin / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D052999:Quinazolinones / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology*
chemical_list: C521524:3-amino-7-(3-(1-aminoethyl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-1H-quinazoline-2,4-dione; D049933:Aminocoumarins; D001430:Bacteriocins; D029968:Escherichia coli Proteins; D011728:Pyridones; D011759:Pyrrolidines; C485384:Qnr protein, E coli; D052999:Quinazolinones; D015363:Quinolones; C000600627:gyramide A; C020411:microcin; D009675:Novobiocin; C093440:ABT 719; D027081:DNA Gyrase; C004628:coumermycin